Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury

Journal of Pain Research

Volumn 6, Issue , 2013, Pages 539-547

  Snedecor, Sonya J ^a   Sudharshan, Lavanya ^a   Cappelleri, Joseph C ^b   Sadosky, Alesia ^b   Desai, Pooja ^c   Jalundhwala, Yash J ^d   Botteman, Marc ^a  

^a PHARMERIT INTERNATIONAL   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Indirect comparison; Neuropathic pain; Pharmacologic management; Spinal cord injury; Systematic review

Indexed keywords

AMITRIPTYLINE; DRONABINOL; DULOXETINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; MEXILETINE; PLACEBO; PREGABALIN; TRAMADOL;

11 POINT NUMERIC RATING SCALE; ANALGESIA; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; META ANALYSIS; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; QUANTITATIVE STUDY; REVIEW; SPINAL CORD INJURY; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT WITHDRAWAL; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 84880194275     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: 10.2147/JPR.S45966     Document Type: Review

References (32)

1. van den Berg ME, Castellote JM, Mahillo-Fernandez I, de Pedro-Cuesta J. Incidence of spinal cord injury worldwide: a systematic review. Neuroepidemiology. 2010;34(3):184-192.
2. National Spinal Cord Injury Statistical Center. Spinal Cord Injury Facts and Figures at a Glance. Birmingham (AL): National SCI Statistical Center; 2013. Available from: https://www.nscisc.uab.edu/PublicDocuments/fact_figures_docs/Facts%202013.pdf. Accessed June 4, 2013.
3. Westgren N, Levi R. Quality of life and traumatic spinal cord injury. Arch Phys Med Rehabil. 1998;79(11):1433-1439.
4. Leduc BE, Lepage Y. Health-related quality of life after spinal cord injury. Disabil Rehabil. 2002;24(4):196-202.
5. Migliorini CE, New PW, Tonge BJ. Quality of life in adults with spinal cord injury living in the community. Spinal Cord. 2011;49(3): 365-370.
6. Treede RD, Jensen T, Campbell JN, etal. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630-1635.
7. Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology. 2007;68(15):1178-1182.
8. Attal N, Cruccu G, Baron R, etal. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010revision. Eur J Neurol. 2010;17(9):1113-1123, e67-e88.
9. Dworkin RH, O'Connor AB, Audette J, etal. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3 Suppl):S3-S14.
10. Baastrup C, Finnerup NB. Pharmacological management of neuropathic pain following spinal cord injury. CNS Drugs. 2008;22(6):455-475.
11. Attal N, Mazaltarine G, Perrouin-Verbe B, Albert T. Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (Oral, transdermal, intravenous). Ann Phys Rehabil Med. 2009;52(2):124-141.
12. Teasell RW, Mehta S, Aubut JA, etal. A systematic review of pharmacologic treatments of pain after spinal cord injury. Arch Phys Med Rehabil. 2010;91(5):816-831.
13. Snedecor SJ, Sudharshan L, Cappelleri JC, Sadosky A, Mehta S, Botteman M. Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Pract. [Epub March 28, 2013.]
14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
15. Jadad AR, Moore RA, Carroll D, etal. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
16. Watson CP, Gilron I, Sawynok J. A qualitative systematic review of head-to-head randomized controlled trials of oral analgesics in neuropathic pain. Pain Res Manag. 2010;15(3):147-157.
17. Vargas-Espinosa ML, Sanmartí-Garcia G, Vázquez-Delgado E, Gay-Escoda C. Antiepileptic drugs for the treatment of neuropathic pain: a systematic review. Med Oral Patol Oral Cir Bucal. 2012;17(5): e786-e793.
18. Higgins JP, Altman DG, Gotzsche PC, etal. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
19. Dworkin RH, Turk DC, Farrar JT, etal. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1-2):9-19.
20. Cardenas D, Warms C, Turner J, Marshall H, Brooke M, Loeser JD. Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain. 2002;96(3):365-373.
21. Chiou-Tan F, Tuel S, Johnson J, Priebe MM, Hirsh D, Strayer J. Effect of mexiletine on spinal cord injury dysesthetic pain. Am J Phys Med Rehabil. 1996;75(2):84-87.
22. Finnerup N, Sindrup S, Bach F, Johannesen I, Jensen T. Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain. 2002;96(3): 375-383.
23. Finnerup NB, Grydehøj J, Bing J, etal. Levetiracetam in spinal cord injury pain: a randomized controlled trial. Spinal Cord. 2009;47(12): 861-867.
24. Levendoglu F, Ogün C, Ozerbil O, Ogün T, Ugurlu H. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine. 2004;29(7):743-751.
25. Norrbrink C, Lundeberg T. Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial. Clin J Pain. 2009;25(3):177-184.
26. Rintala DH, Holmes SA, Courtade D, Fiess RN, Tastard LV, Loubser PG. Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil. 2007;88(12):1547-1560.
27. Rintala DH, Fiess RN, Tan G, Holmes SA, Bruel BM. Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study. Am J Phys Med Rehabil. 2010;89(10):840-848.
28. Siddall P, Cousins M, Otte A, Griesing T, Chambers R, Murphy TK. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology. 2006;67(10):1792-1800.
29. Tai Q, Kirshblum S, Chen B, Millis S, Johnston M, DeLisa J. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. J Spinal Cord Med. 2002;25(2):100-105.
30. Vranken JH, Dijkgraaf MG, Kruis MR, van der Vegt MH, Hollmann MW, Heesen M. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain. 2008;136(1-2):150-157.
31. Vranken JH, Hollmann MW, van der Vegt MH, etal. Duloxetine in patients with central neuropathic pain caused by spinal cord injury or stroke: a randomized, double-blind, placebo-controlled trial. Pain. 2011;152(2):267-273.
32. Cardenas DD, Nieshoff EC, Sanin L, etal. A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury. Neurology. 2013;80(6):533-539.